| Application | Recommended Dilution |
|---|---|
| ELISA | 1:5000-1:50000 |
| IHC | 1:50-1:200 |
CCR1, also known as CD191, is a G protein-coupled receptor that plays a central role in immune cell trafficking and inflammatory responses. As a receptor for multiple chemokines including MIP-1α and RANTES, CCR1 mediates the recruitment of leukocytes to sites of inflammation and infection, making it a compelling target for researchers investigating immune regulation, inflammatory diseases, and host defense mechanisms.
This recombinant monoclonal antibody, clone 15B4, offers researchers the consistency and reliability that comes with sequence-defined production. Unlike traditional hybridoma-derived antibodies, recombinant technology ensures lot-to-lot reproducibility, allowing you to maintain experimental continuity across long-term studies without the variability that can complicate data interpretation.
Functional validation demonstrates robust binding activity, with the antibody recognizing immobilized human CCR1 protein at an EC50 of 9.690-10.94 ng/mL in ELISA format, while showing no binding to VLP negative controls. This specificity has been further confirmed through immunohistochemistry on paraffin-embedded human lymph node tissue, where the antibody successfully detected CCR1 at 1:50 dilution using citrate buffer antigen retrieval. The lymph node represents a particularly relevant tissue for CCR1 studies given the receptor's importance in lymphocyte homing and immune cell organization within secondary lymphoid organs.
Supplied in a glycerol-based PBS buffer with Proclin 300 preservative, this antibody is validated for ELISA applications at dilutions ranging from 1:5000 to 1:50000 and for immunohistochemistry at 1:50 to 1:200. Whether you're characterizing chemokine receptor expression patterns, investigating inflammatory pathways, or exploring CCR1's role in disease contexts, this antibody provides a dependable tool for your immunology research.
Email: support@cusabio.com
Distributors Worldwide